Second, the tail vein injection of in vitro clonally expanded ECs is an artificial means to test our hypothesis that clonally selected CD117+ ECs contribute to the occlusive pulmonary arteriopathy in PAH. Here, KIT is linked to pulmonary arterial hypertension.